EXFORGE

This brand name is authorized in United States. It is also authorized in Australia, Austria, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug EXFORGE contains a combination of these active pharmaceutical ingredients (APIs):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine
2	Valsartan UNII 80M03YXJ7I - VALSARTAN
	Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II.
	Read more about Valsartan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EXFORGE Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DB01	Valsartan and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5459H, 5460J, 9375K, 9376L, 9377M
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00012931, 00013534, 00014350, 00581327, 00581356, 00581391, 00581422, 00581474, 00581497, 01231799, 04708813, 05386688, 05386694, 06142617, 06142652, 06142681, 06439406, 06439412, 06441343, 06441366, 07052419, 07289593, 07289624, 07289653, 09194425, 09543506, 09543512, 09779019, 09779456, 09779462, 10066253, 10114785, 10114791, 10114816, 10114822, 10114839, 10114845, 10114851, 10114868, 10172736, 10288574, 10298354, 10298383, 10789313, 11045951, 11089730, 11380069, 11515782, 12483185, 12483191, 12483216, 12483222, 12561229, 15235281, 16008825, 16528418, 17523133, 17847433
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2208-MEE-0616, 2459-MEE-0916, 29728-04-11, 29739-04-11, 29987-09-11
EE	Ravimiamet	1235528, 1235539, 1235540, 1235551, 1235562, 1235573, 1235584, 1235595, 1235607, 1235618, 1235629, 1235630, 1235641, 1235652, 1235663, 1235674, 1235685, 1235696, 1235708, 1235719, 1235720, 1235731, 1235742, 1235753
ES	Centro de información online de medicamentos de la AEMPS	06370011, 06370019
FI	Lääkealan turvallisuus- ja kehittämiskeskus	074042, 074051, 074060, 074069, 074078, 074087
FR	Base de données publique des médicaments	60058008, 61695837, 66996659
GB	Medicines & Healthcare Products Regulatory Agency	111612, 111616, 111619, 196118, 196120, 196122, 374370, 374372
HK	Department of Health Drug Office	56183, 56184, 56185, 59786, 59787, 60451, 60452, 60453
IE	Health Products Regulatory Authority	23401, 23410, 23419, 23423, 23425, 32627, 32628, 32651, 32660, 32661, 32663
IL	מִשְׂרַד הַבְּרִיאוּת	6145, 6146, 6148
JP	医薬品医療機器総合機構	2149114F1021, 2149114F2028
LT	Valstybinė vaistų kontrolės tarnyba	1005477, 1005478, 1028134, 1028135, 1028136, 1028137, 1028138, 1028139, 1028140, 1028141, 1028142, 1028143, 1028145, 1028146, 1028147, 1028148, 1028149, 1028150, 1028151, 1028153, 1028154, 1028155, 1028156, 1028157, 1056612, 1056613, 1056614, 1056615, 1056616, 1056617, 1056618, 1056619, 1056620, 1056621, 1056622, 1056623, 1058745, 1058746, 1058747
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	159M2007
NG	Registered Drug Product Database	B4-1701
Switch country to Nigeria in order to find specific presentations of EXFORGE
NL	Z-Index G-Standaard, PRK	82686, 82694, 82708
NZ	Medicines and Medical Devices Safety Authority	12433, 12434, 12435
PL	Rejestru Produktów Leczniczych	100171336, 100174174, 100174180
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64721001, W64721002, W64721003, W64721004, W64721005, W64721006, W64721007, W64721008, W64721009, W64721010, W64721011, W64722001, W64722002, W64722003, W64722004, W64722005, W64722006, W64722007, W64722008, W64722009, W64722010, W64722011, W64723001, W64723002, W64723003, W64723004, W64723005, W64723006, W64723007, W64723008, W64723009, W64723010, W64723011
SG	Health Sciences Authority	13416P, 13417P, 13418P
TN	Direction de la Pharmacie et du Médicament	10283201, 10283202, 10283203
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504091199, 8699504091205
US	FDA, National Drug Code	0078-0488, 0078-0489, 0078-0490, 0078-0491
ZA	Health Products Regulatory Authority	41/7.1.3/0290, 41/7.1.3/0291, 41/7.1.3/0292, 41/7.1.3/0770, 41/7.1.3/0771